Log In
Print this Print this

ABBV-8E12, C2N-8E12

  Manage Alerts
Collapse Summary General Information
Company C2N Diagnostics LLC
DescriptionRecombinant humanized antibody targeting microtubule-associated protein tau (tau; MAPT; FTDP-17) in neurofibrillary tangles in the brain
Molecular Target Microtubule-associated protein tau (tau) (MAPT) (FTDP-17)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationProgressive supranuclear palsy (PSP)
Indication DetailsTreat progressive supranuclear palsy (PSP)
Regulatory Designation U.S. - Orphan Drug (Treat progressive supranuclear palsy (PSP))
PartnerAbbVie Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today